Thyrotoxicosis and dilated cardiomyopathy in developing countries

Abstract

Background Thyrotoxicosis is the state of thyroid hormone excess. But, in sub-Saharan Africa (SSA), specifically Northern Ethiopia, scientific evidence about thyrotoxicosis and its cardiac complications like dilated cardiomyopathy is limited. Therefore, this study aimed to explore the thyrotoxicosis presentation and management and identify factors associated with dilated cardiomyopathy in a tertiary hospital in Northern Ethiopia. Methods An institution-based cross-sectional study was conducted in Ayder Comprehensive Specialized Hospital from 2017 to 2018. Data from 200 thyrotoxicosis cases were collected using a structured questionnaire. After describing variables, logistic regression was conducted to identify independent predictors of dilated cardiomyopathy. Statistical significance was declared at p \u2009<\u20090.05. Results Mean age at presentation of thyrotoxicosis was 45 years and females accounted for 89\u2009% of the cases. The most frequent etiology was multinodular toxic goiter (51.5\u2009%). As well, the most common symptoms and signs were palpitation and goiter respectively. Thyroid storm occurred in 6\u2009% of the cases. Out of 89 patients subjected to echocardiography, 35 (39.3\u2009%) of them had dilated cardiomyopathy. And, the odds of dilated cardiomyopathy were higher in patients who had atrial fibrillation (AOR\u2009=\u200915.95, 95\u2009% CI:5.89–38.16, p \u2009=\u20090.001) and tachycardia (AOR\u2009=\u20092.73, 95\u2009% CI:1.04–7.15, p \u2009=\u20090.040). All patients took propylthiouracil and 13.0\u2009% of them experienced its side effects. Concerning β-blockers, propranolol was the most commonly (78.5\u2009% of the cases) used drug followed by atenolol (15.0\u2009%). Six patients underwent surgery. Conclusions In developing countries like Ethiopia, patients with thyrotoxicosis have no access to methimazole which is the first-line anti-thyroid drug. Besides, they greatly suffer from dilated cardiomyopathy (due to late presentation) and side effects of propylthiouracil. Therefore, we recommend that patients should get adequate health information about thyrotoxicosis and anti-thyroid drugs including their side effects. Additionally, hospitals and other concerned bodies should also avail of TSH tests and methimazole at an affordable cost. Furthermore, community awareness about iodized salt and iodine-rich foods should be enhanced.